Follow-up of gastric cancer: A review

Gastric Cancer

Volumn 9, Issue 2, 2006, Pages 74-81

  Whiting, John ^a,b   Sano, Takeshi ^b   Saka, Makoto ^b   Fukagawa, Takeo ^b   Katai, Hitoshi ^b   Sasako, Mitsuru ^b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Follow up; Gastrectomy; Recurrence; Stomach neoplasms

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; FOLLOW UP; GASTRECTOMY; HEALTH CARE POLICY; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STOMACH CARCINOMA; SURVIVAL;

FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; NEOPLASM RECURRENCE, LOCAL; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33745162223     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-006-0360-0     Document Type: Review

References (67)

1. MT Hallissey WH Allum AJ Jewkes DJ Ellis JW Fielding 1990 Early detection of gastric cancer BMJ 301 513 5
2. HM Sue-Ling D Johnston IG Martin MF Dixon MR Lansdown MJ [tmp] McMahon 1993 Gastric cancer: a curable disease in Britain BMJ 307 591 6
3. AG Renehan M Egger MP Saunders ST O'Dwyer 2002 Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials BMJ 324 813 6
4. Guidelines for the management of colorectal cancer. www.asgbi.org.uk 2001 cited; available from: www.asgbi.org.uk
5. CE Desch AB Benson 3rd TJ Smith PJ Flynn C Krause CL Loprinzi 1999 Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology J Clin Oncol 17 1312 21
6. TJ Smith NE Davidson DV Schapira E Grunfeld HB Muss VG Vogel 3rd 1999 American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines J Clin Oncol 17 1080 2
7. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer 1997 Adopted on May 16, 1997 by the American Society of Clinical Oncology J Clin Oncol 15 2996 3018
8. T Nakajima 2002 Gastric cancer treatment guidelines in Japan Gastric Cancer 5 1 5
9. FE Johnson KS Virgo 1997 Cancer patient follow-up Mosby St Louis
10. F Roviello D Marrelli G de Manzoni P Morgagni A Di Leo L Saragoni 2003 Prospective study of peritoneal recurrence after curative surgery for gastric cancer Br J Surg 90 1113 9
11. Y Maehara S Hasuda T Koga E Tokunaga Y Kakeji K Sugimachi 2000 Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer Br J Surg 87 353 7
12. N Shiraishi M Inomata N Osawa K Yasuda Y Adachi S Kitano 2000 Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses Cancer 89 255 61
13. S Ohno T Fujii S Ueda T Nakamoto S Kinugasa H Yoshimura 2003 Predictive factors and timing for liver recurrence after curative resection of gastric carcinoma Am J Surg 185 258 63
14. RE Schwarz K Zagala-Nevarez 2002 Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy Ann Surg Oncol 9 394 400
15. N Arima K Adachi T Katsube K Amano S Ishihara M Watanabe 1999 Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment (see comment) J Clin Gastroenterol 29 44 7
16. N Uemura T Mukai S Okamoto S Yamaguchi H Mashiba K Taniyama 1997 Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer Cancer Epidemiol Biomarkers Prev 6 639 42
17. LL Gunderson H Sosin 1982 Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy Int J Radiat Oncol Biol Phy 8 1 11
18. CH Yoo SH Noh DW Shin SH Choi JS Min 2000 Recurrence following curative resection for gastric carcinoma Br J Surg 87 236 42
19. H Katai K Maruyama M Sasako T Sano K Okajima T Kinoshita 1994 Mode of recurrence after gastric cancer surgery Dig Surg 11 99 103
20. T Sano M Sasako T Kinoshita K Maruyama 1993 Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature (see comment) Cancer 72 3174 8
21. HJ Lee YH Kim WH Kim KU Lee KJ Choe JP Kim 2003 Clinicopathological analysis for recurrence of early gastric cancer Jpn J Clin Oncol 33 209 14
22. Y Kodera S Ito Y Yamamura Y Mochizuki M Fujiwara K Hibi 2003 Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit Ann Surg Oncol 10 898 902
23. JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction (see comment) New Engl J Med 345 725 30
24. SI Hironaka N Boku A Ohtsu F Nagashima Y Sano M Muto 2000 Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with bone metastasis Gastric Cancer 3 19 23
25. AC Tersmette GJ Offerhaus KW Tersmette FM Giardiello GW Moore GN Tytgat 1990 Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions Cancer Res 50 6486 9
26. G Lundegardh HO Adami C Helmick M Zack O Meirik 1988 Stomach cancer after partial gastrectomy for benign ulcer disease N Engl J Med 319 195 200
27. S Kikuchi M Sato N Katada S Sakuramoto H Shimao A Kakita 2003 Efficacy of endoscopic surveillance of the upper gastrointestinal tract following distal gastrectomy for early gastric cancer Hepatogastroenterology 50 1704 7
28. S Thorban K Bottcher M Etter JD Roder R Busch JR Siewert 2000 Prognostic factors in gastric stump carcinoma Ann Surg 231 188 94
29. SL Han YW Hua CH Wang SQ Ji J Zhuang 2003 Metastatic pattern of lymph node and surgery for gastric stump cancer J Surg Oncol 82 241 6
30. M Sasako K Maruyama T Kinoshita K Okabayashi 1991 Surgical treatment of carcinoma of the gastric stump Br J Surg 78 822 4
31. CN Chen WJ Lee PH Lee KJ Chang KM Chen 1996 Clinicopathologic characteristics and prognosis of gastric stump cancer J Clin Gastroenterol 23 251 5
32. F Tas N Faruk Aykan A Aydiner V Yasasever E Topuz 2001 Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer Am J Clin Oncol 24 148 9
33. IR Lai WJ Lee MT Huang HH Lin 2002 Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence Hepatogastroenterology 49 1157 60
34. Y Takahashi T Takeuchi J Sakamoto T Touge M Mai H Ohkura 2003 The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study Gastric Cancer 6 142 5
35. Y Ikeda M Mori K Kajiyama T Kamakura Y Maehara Y Haraguchi 1996 Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer Hepatogastroenterology 43 1281 7
36. HK Ha HH Kim HS Kim MH Lee KT Kim KS Shinn 1993 Local recurrence after surgery for gastric carcinoma: CT findings AJR Am J Roentgenol 161 975 7
37. T Sano S Yamamoto M Sasako 2002 Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan Clinical Oncology Group study JCOG 0110-MF Jpn J Clin Oncol 32 363 4
38. K Kinkel Y Lu M Both RS Warren RF Thoeni 2002 Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis Radiology 224 748 56
39. EK Insko MS Levine BA Birnbaum JE Jacobs 2003 Benign and malignant lesions of the stomach: evaluation of CT criteria for differentiation Radiology 228 166 71
40. MA Meyers J [tmp] McSweeney 1972 Secondary neoplasms of the bowel Radiology 105 1 11
41. H Jadvar R Tatlidil AA Garcia PS Conti 2003 Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography (erratum appears in Clin Radiol 2003 Jul;58:570) Clin Radiol 58 215 21
42. H Bohner T Zimmer W Hopfenmuller G Berger HJ Buhr 2000 Detection and prognosis of recurrent gastric cancer - is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology 47 1489 94
43. T Inada Y Ogata J Andoh I Ozawa J Matsui S Hishinuma 1994 Significance of para-aortic lymph node dissection in patients with advanced and recurrent gastric cancer Anticancer Res 14 677 82
44. I Takeyoshi S Ohwada T Ogawa Y Kawashima T Ohya S Kawate 2000 The resection of non-hepatic intraabdominal recurrence of gastric cancer Hepatogastroenterology 47 1479 81
45. MA Choti JV Sitzmann MF Tiburi W Sumetchotimetha R Rangsin RD Schulick 2002 Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 759 66
46. M Minagawa M Makuuchi G Torzilli T Takayama S Kawasaki T Kosuge 2000 Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results Ann Surg 231 487 99
47. T Ochiai M Sasako S Mizuno T Kinoshita T Takayama T Kosuge 1994 Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors Br J Surg 81 1175 8
48. M Miyazaki H Itoh K Nakagawa S Ambiru H Shimizu A Togawa 1997 Hepatic resection of liver metastases from gastric carcinoma Am J Gastroenterol 92 490 3
49. K Shirabe M Shimada T Matsumata H Higashi Y Yakeishi S Wakiyama 2003 Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection Hepatogastroenterology 50 1560 3
50. Y Sakamoto S Ohyama J Yamamoto K Yamada M Seki K Ohta 2003 Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients Surgery 133 507 11
51. J Zacherl M Zacherl C Scheuba R Steininger E Wenzl F Muhlbacher 2002 Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma J Gastrointest Surg 6 682 9
52. A Saiura N Umekita S Inoue T Maeshiro S Miyamoto Y Matsui 2002 Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer Hepatogastroenterology 49 1062 5
53. K Okano T Maeba K Ishimura Y Karasawa F Goda H Wakabayashi 2002 Hepatic resection for metastatic tumors from gastric cancer Ann Surg 235 86 91
54. HH Hartgrink H Putter E Klein Kranenbarg JJ Bonenkamp CJ van de Velde 2002 Value of palliative resection in gastric cancer Br J Surg 89 1438 43
55. T Haugstvedt A Viste GE Eide O Soreide 1989 The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial World J Surg 13 617 21 discussion 621-2
56. JA Wils HO Klein DJ Wagener H Bleiberg H Reis F Korsten 1991 Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group J Clin Oncol 9 827 31
57. AM Murad FF Santiago A Petroianu PR Rocha MA Rodrigues M Rausch 1993 Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37 41
58. U Vanhoefer P Rougier H Wilke MP Ducreux AJ Lacave E Van Cutsem 2000 Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group (comment) J Clin Oncol 18 2648 57
59. T Moynihan R Hansen T Anderson E Quebbeman P Beatty R Ausman 1988 Continuous 5-fluorouracil infusion in advanced gastric carcinoma Am J Clin Oncol 11 461 4
60. A Ohtsu Y Shimada K Shirao N Boku I Hyodo H Saito 2003 Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205) J Clin Oncol 21 54 9
61. HO Douglass Jr PT Lavin A Goudsmit DJ Klaassen AR Paul 1984 An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277) J Clin Oncol 2 1372 81
62. A Webb D Cunningham JH Scarffe P Harper A Norman JK Joffe 1997 Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 261 7
63. JS Waters A Norman D Cunningham JH Scarffe A Webb P Harper 1999 Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial Br J Cancer 80 269 72
64. J Wils H Bleiberg O Dalesio G Blijham N Mulder A Planting 1986 An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer J Clin Oncol 4 1799 803
65. C Stael von Holstein S Eriksson B Huldt E Hammar 1991 Endoscopic screening during 17 years for gastric stump carcinoma. A prospective clinical trial Scand J Gastroenterol 26 1020 6
66. Cancer Statistics in Japan. (Cited; available from: http://www.ncc.go.jp/ en/statistics/index.html)
67. A Berrington de Gonzalez S Darby 2004 Risk of cancer from diagnostic X-rays: estimates for the United Kingdom and 14 other countries Lancet 363 345 51